View Pages
Yum Brands faces investor questions as a Taco Bell-linked cyclospora outbreak threatens Q2 results and reputation ahead of earnings.
Editorial companion
CNBC's Brandon Gomez homed in on something investors already feared: a Cyclospora outbreak tied to Taco Bell will dominate Yum! Brands' second-quarter call and steal airtime from routine metric reviews. Food-safety stories behave like magnets, pulling every question toward customer traffic, franchise stress and PR damage control. For shareholders, the debate shifts from whether Yum grew sales and profits to whether this incident dents consumer trust enough to matter for the next few quarters.
View Pages
Bullish Gator Snapshot
YUM rates Neutral overall. The fundamental read is neutral: the company passes 4 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.50); revenue is growing about 6.3% per year; net income is growing about 6.1% per year. The technical picture is neutral: price is 1.4% below the 200-day moving average; 3.1% above the 50-day; the 50/200 relationship is in a Death cross. Sentiment is neutral (composite 50/100), based on 7 news articles from recent coverage.